Related Experiment Video
Updated: Apr 27, 2026
06:31
Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
2.8K
Tissue engineering in congenital diaphragmatic hernia.
1Department of Surgery, Boston Children׳s Hospital, 300 Longwood Ave, Fegan 3, Boston, Massachusetts 02115; Department of Surgery, Harvard Medical School, Boston, Massachusetts.
Seminars in Pediatric Surgery
|July 5, 2014
Summary
Engineered diaphragmatic repair using cellularized grafts offers a promising solution for congenital diaphragmatic defects. This regenerative medicine approach aligns with fetal tissue engineering and mesenchymal stem cell research.
Area of Science:
- Regenerative medicine
- Fetal tissue engineering
- Neonatal surgery
Background:
- Congenital diaphragmatic defects require innovative repair strategies.
- Understanding diaphragmatic hernia recurrence mechanisms is crucial.
- Fetal mesenchymal stem cells offer potential for regenerative therapies.
Purpose of the Study:
- To explore cellularized grafts as an alternative for neonatal diaphragmatic defect repair.
- To investigate the biological justification for this approach based on hernia recurrence.
- To align regenerative strategies with fetal stem cell-based constructs.
Main Methods:
- Development of cellularized grafts for diaphragmatic repair.
- Investigation of regenerative medicine principles in a neonatal context.
- Exploration of fetal mesenchymal stem cell applications.
Main Results:
- Cellularized grafts are biologically justifiable for diaphragmatic hernia repair.
- This approach is compatible with fetal mesenchymal stem cell-based constructs.
- Neonatal tissue engineering has advanced significantly in this area.
Conclusions:
- Engineered diaphragmatic repair represents a key advancement in perinatal regenerative medicine.
- Clinical applications of these tissue-engineered grafts are anticipated.
- This research bridges fetal tissue engineering and neonatal clinical needs.
